Skip to content

Achieve Life Sciences ACHV Other comprehensive income (loss)

Other comprehensive income (loss) at other companies

Seaboard logo
SeaboardSEB
$7M+150%
SHA
SharonAI Holdings, Inc. Class A Common StockSHAZ
-$200.18K-288%
CBIZ logo
CBIZCBZ
$1.73M+240%
TFS Financial logo
TFS FinancialTFSL
$12.43M+148%
Regenxbio logo
RegenxbioRGNX
-$183K-771%
MGP Ingredients logo
MGP IngredientsMGPI
-$265K-190%

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0
Free cash flow-$12.4M

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeLossNetOfTax.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's other comprehensive income (loss).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's other comprehensive income (loss)?
Achieve Life Sciences (ACHV) reported other comprehensive income (loss) of -$8K in Q1 2026.
How has Achieve Life Sciences's other comprehensive income (loss) changed year-over-year?
Achieve Life Sciences's other comprehensive income (loss) increased by 68.0% year-over-year, from -$25K to -$8K.
What does other comprehensive income (loss) mean?
The total of all items of comprehensive income that are excluded from net income under accounting standards. This includes adjustments such as foreign currency translation and unrealized gains or losses on specific financial instruments. It provides a broader view of the company's total financial performance beyond standard operating results.